Teva Pharmaceutical's total assets for Q3 2025 were $39.86B, a decrease of -0.69% from the previous quarter. DE:TEV total liabilities were $21.11B for the fiscal quarter, a -36.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.